Biocon's drug Itolizumab gets DCGI nod for use in moderate to severe Covid-19 patients
Jul 11, 2020
Bengaluru (Karnataka) [India], July 11 : Biopharmaceutical major Biocon Ltd said on Saturday it has received approval from the Drugs Controller General of India...